A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen.

[1]  S. Goff,et al.  Structure of the rhesus monkey TRIM5α PRYSPRY domain, the HIV capsid recognition module , 2012, Proceedings of the National Academy of Sciences.

[2]  F. Clavel,et al.  Gag Cytotoxic T Lymphocyte Escape Mutations Can Increase Sensitivity of HIV-1 to Human TRIM5α, Linking Intrinsic and Acquired Immunity , 2011, Journal of Virology.

[3]  T. Kigawa,et al.  Contribution of E3-Ubiquitin Ligase Activity to HIV-1 Restriction by TRIM5αrh: Structure of the RING Domain of TRIM5α , 2011, Journal of Virology.

[4]  Brian Fury,et al.  Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  A. Gronenborn,et al.  Rhesus TRIM5α Disrupts the HIV-1 Capsid at the InterHexamer Interfaces , 2011, PLoS pathogens.

[6]  J. Sodroski,et al.  Hexagonal assembly of a restricting TRIM5α protein , 2010, Proceedings of the National Academy of Sciences.

[7]  Rajendra Singh,et al.  BST-2/tetherin: a new component of the innate immune response to enveloped viruses. , 2010, Trends in microbiology.

[8]  V. Simon,et al.  Immune mechanisms of HIV control. , 2010, Current opinion in immunology.

[9]  C. Aiken,et al.  TRIM5α Disrupts the Structure of Assembled HIV-1 Capsid Complexes In Vitro , 2010, Journal of Virology.

[10]  M. Grütter,et al.  Generation of human TRIM5α mutants with high HIV-1 restriction activity , 2010, Gene Therapy.

[11]  R. Sharan,et al.  I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.

[12]  J. Luban,et al.  HIV-1 Vpu Neutralizes the Antiviral Factor Tetherin/BST-2 by Binding It and Directing Its Beta-TrCP2-Dependent Degradation , 2009, PLoS pathogens.

[13]  J. Sodroski,et al.  A B-Box 2 Surface Patch Important for TRIM5α Self-Association, Capsid Binding Avidity, and Retrovirus Restriction , 2009, Journal of Virology.

[14]  S. Guadagnini,et al.  Simultaneous Cell-to-Cell Transmission of Human Immunodeficiency Virus to Multiple Targets through Polysynapses , 2009, Journal of Virology.

[15]  H. Kräusslich,et al.  HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. , 2009, Cell host & microbe.

[16]  O. Fackler,et al.  HIV-1 at the immunological and T-lymphocytic virological synapse , 2008, Biological chemistry.

[17]  J. Sodroski,et al.  Biochemical and Biophysical Characterization of a Chimeric TRIM21-TRIM5α Protein , 2008, Journal of Virology.

[18]  J. Sodroski,et al.  Biochemical Characterization of a Recombinant TRIM5α Protein That Restricts Human Immunodeficiency Virus Type 1 Replication , 2008, Journal of Virology.

[19]  Joseph Sodroski,et al.  Mode of Transmission Affects the Sensitivity of Human Immunodeficiency Virus Type 1 to Restriction by Rhesus TRIM5α , 2008, Journal of Virology.

[20]  J. Sodroski,et al.  A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus. , 2008, Virology.

[21]  C. Aiken,et al.  Proteasomal Degradation of TRIM5α during Retrovirus Restriction , 2008, PLoS pathogens.

[22]  Q. Sattentau,et al.  Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. , 2008, Blood.

[23]  D. Pérez-Caballero,et al.  No effect of endogenous TRIM5α on HIV-1 production , 2008, Nature Medicine.

[24]  T. Hope,et al.  Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5α , 2008, The Journal of cell biology.

[25]  P. Uchil,et al.  TRIM E3 Ligases Interfere with Early and Late Stages of the Retroviral Life Cycle , 2008, PLoS pathogens.

[26]  John J Rossi,et al.  Genetic therapies against HIV , 2007, Nature Biotechnology.

[27]  L. Berthoux,et al.  Both TRIM5α and TRIMCyp have only weak antiviral activity in canine D17 cells , 2007, Retrovirology.

[28]  Y. Ikeda,et al.  Rhesus monkey TRIM5α restricts HIV-1 production through rapid degradation of viral Gag polyproteins , 2007, Nature Medicine.

[29]  J. Sodroski,et al.  The Human TRIM5α Restriction Factor Mediates Accelerated Uncoating of the N-Tropic Murine Leukemia Virus Capsid , 2006, Journal of Virology.

[30]  A. Engelman,et al.  Proteasome Inhibition Reveals that a Functional Preintegration Complex Intermediate Can Be Generated during Restriction by Diverse TRIM5 Proteins , 2006, Journal of Virology.

[31]  M. Yap,et al.  All Three Variable Regions of the TRIM5α B30.2 Domain Can Contribute to the Specificity of Retrovirus Restriction , 2006, Journal of Virology.

[32]  Joseph Sodroski,et al.  Removal of Arginine 332 Allows Human TRIM5α To Bind Human Immunodeficiency Virus Capsids and To Restrict Infection , 2006, Journal of Virology.

[33]  C. Aiken,et al.  Saturation of TRIM5 alpha-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid. , 2006, Virology.

[34]  J. Sodroski,et al.  Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. , 2006, Virology.

[35]  T. Hope,et al.  Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Joseph Sodroski,et al.  Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Luban,et al.  Arsenic Counteracts Human Immunodeficiency Virus Type 1 Restriction by Various TRIM5 Orthologues in a Cell Type-Dependent Manner , 2006, Journal of Virology.

[38]  B. Cullen.  Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors , 2006, Journal of Virology.

[39]  D. Pérez-Caballero,et al.  Restriction of Human Immunodeficiency Virus Type 1 by TRIM-CypA Occurs with Rapid Kinetics and Independently of Cytoplasmic Bodies, Ubiquitin, and Proteasome Activity , 2005, Journal of Virology.

[40]  J. Luban,et al.  Cyclophilin A is required for TRIM5α-mediated resistance to HIV-1 in Old World monkey cells , 2005 .

[41]  R. Akkina,et al.  TRIM5alpharh expression restricts HIV-1 infection in lentiviral vector-transduced CD34+-cell-derived macrophages. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  A. Yang,et al.  Human Tripartite Motif 5α Domains Responsible for Retrovirus Restriction Activity and Specificity , 2005, Journal of Virology.

[43]  J. Luban,et al.  TRIM5α selectively binds a restriction-sensitive retroviral capsid , 2005, Retrovirology.

[44]  J. Luban,et al.  Disruption of Human TRIM5α Antiviral Activity by Nonhuman Primate Orthologues , 2005, Journal of Virology.

[45]  J. Sodroski,et al.  The B30.2(SPRY) Domain of the Retroviral Restriction Factor TRIM5α Exhibits Lineage-Specific Length and Sequence Variation in Primates , 2005, Journal of Virology.

[46]  J. Sodroski,et al.  Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5α Determines the Potency of Human Immunodeficiency Virus Restriction , 2005, Journal of Virology.

[47]  Michael Emerman,et al.  Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  C. Aiken,et al.  Structural Requirements for Recognition of the Human Immunodeficiency Virus Type 1 Core during Host Restriction in Owl Monkey Cells , 2005, Journal of Virology.

[49]  Jonathan P. Stoye,et al.  A Single Amino Acid Change in the SPRY Domain of Human Trim5α Leads to HIV-1 Restriction , 2005, Current Biology.

[50]  J. Luban,et al.  Lv1 Inhibition of Human Immunodeficiency Virus Type 1 Is Counteracted by Factors That Stimulate Synthesis or Nuclear Translocation of Viral cDNA , 2004, Journal of Virology.

[51]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[52]  Y. Ikeda,et al.  Influence of gag on Human Immunodeficiency Virus Type 1 Species-Specific Tropism , 2004, Journal of Virology.

[53]  Wesley I. Sundquist,et al.  Assembly Properties of the Human Immunodeficiency Virus Type 1 CA Protein , 2004, Journal of Virology.

[54]  B. Strack,et al.  Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway* , 2004, Journal of Biological Chemistry.

[55]  C. M. Owens,et al.  The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.

[56]  M. Marin,et al.  HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation , 2003, Nature Medicine.

[57]  R. König,et al.  Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.

[58]  P. Pandolfi,et al.  As2O3 Enhances Retroviral Reverse Transcription and Counteracts Ref1 Antiviral Activity , 2003, Journal of Virology.

[59]  C. M. Owens,et al.  Human and Simian Immunodeficiency Virus Capsid Proteins Are Major Viral Determinants of Early, Postentry Replication Blocks in Simian Cells , 2003, Journal of Virology.

[60]  P. Bieniasz,et al.  Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Tremblay,et al.  Presence of Host ICAM-1 in Laboratory and Clinical Strains of Human Immunodeficiency Virus Type 1 Increases Virus Infectivity and CD4+-T-Cell Depletion in Human Lymphoid Tissue, a Major Site of Replication In Vivo , 2002, Journal of Virology.

[62]  Luigi Naldini,et al.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.

[63]  R. Naviaux,et al.  The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses , 1996, Journal of virology.

[64]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[65]  W. Sundquist,et al.  Assembly and analysis of conical models for the HIV-1 core. , 1999, Science.

[66]  C. Chuong,et al.  Article type Software , 2007 .